Director, Medicare Innovation Analysis
Section of Hospital Medicine, Department of Medicine
Dr. Zhang is a health economist and health outcomes researcher at the University of Chicago. He has made scientific contributions in a number of fields including: (a) cost-related medication non-adherence (CRN); (b) Medicare Part D; (c) access to, quality and costs of care in the treatments of diabetes, heart failure, and cancer; (d) comorbidity risk adjustment; and (e) other innovative socio-network approaches in care for the elderly. His lead-author articles have appeared in the journals such as Medical Care, the Journal of American Geriatrics Society, the American Journal of Geriatric Psychiatry, the American Journal of Public Health, the Journal of General Internal Medicine, and have been well cited in the literature. He is funded by a NIH grant to develop a novel big-data screening tool to identify and reduce CRN.
Nationally and internationally, Zhang has provided services to a number of professional societies, including serving on the advisory board of AcademyHealth interest group, the Scientific Committee of American Society of Health Economists (ASHEcon), the Scientific Committee of International Health Economics Association (IHEA), the Research Review Committee and Judge for International Society for Pharmacoeconomics and Outcome Research (ISPOR), and as referees of medical research granting bodies of two governments of “Asian Tigers.” He has been invited to present his research findings in at international professional conferences in Copenhagen, Dublin, Paris, and Venice, among others. He is on editorial boards of four professional journals.